Chronic Lymphocytic Leukemia (CLL)

Guidance for Bone Marrow Failure Patients to Protect Against Coronavirus (COVID-19)

This content has been prepared in consultation with AAMDSIF Medical Advisory Board Chair Mikkael Sekeres MD, MS of Sylvester Comprehensive Cancer Center, University of Miami and Co-Chair Olatoyosi Odenike MD of the University of Chicago with additional review by Amy DeZern, MD, Johns Hopkins and Carlos De Castro, MD, Duke. ( November 2022)

Danielle Brander, MD

Institution
Duke Cancer Center
Physician Status
accepting new patients
Primary Disease Area of Focus
Chronic Lymphocytic Leukemia (CLL)
About
Dr. Brander focus on treating chronic lymphocytic leukemia (CLL). The way the CLL affects patients differs because leukemia can be different in different patients, and how it makes them feel can be very different. And, importantly, their goals of treatment are going to be very different. Dr. Brander would like patients to know that she understands that this is a new and different situation for them, and that this is as a partnership for the long haul. She also want them to know that she has compassion for what they are going through. Even though Dr. Brander sees a lot of CLL patients, she is

Website Feedback

Please use this feedback form to report website issues only. For other issues concerning patients and families, please email help@aamds.org or use the Patient and Family Helpline here.